INSIGHTS &
INDUSTRY NEWS

Mertz Taggart follows the publicly traded home-based care companies and reports on their earnings calls each quarter. Take a closer look at the M&A activity that marked Q4 2025.

Discover the journey behind the sale of For Papa’s Sake Home Care—a story of legacy, family, and commitment to compassionate care.

From emotional readiness to working capital disputes, here are seven common challenges agency owners face when selling a home health or hospice business and how to prepare for each one. Insights from Mertz Taggart’s Capital + Strategy panel.

Choosing the right M&A advisor is one of the most important decisions when selling your home care agency. Here are six things to evaluate before you sign.

A breakdown of how the latest Medicaid data release has made home care agencies visible to private equity buyers—and why direct outreach often caps valuation.

After years of uncertainty, hospice M&A has reached a clear inflection point. Q4 2025 marked the strongest transaction volume since 2021, driven by premium platform deals that reset valuation benchmarks and restored buyer confidence. As interest rates ease and the valuation gap narrows, private equity is deploying capital more aggressively. According to Cory Mertz, buyers are back—but the bar for clinical integrity and compliance has never been higher.

Mertz Taggart follows the publicly traded home-based care companies and reports on their earnings calls each quarter. Take a closer look at the M&A activity that marked Q3 2025.

If you’re an owner of a home-based care agency, chances are you are getting approached regularly, even daily, by private equity groups, strategic buyers, independent sponsors, and search funds, all eager to talk. Some may have suggested attractive “multiples” that they will pay for companies like yours. It sounds flattering, even tempting. You think, “I’ve got a willing buyer, let’s keep it simple and cut out the middleman.” Learn more about why hiring an advisor will "save y

The recap of Behavioral Health M&A activity is now available in our M&A Report! Read all about the transactions that marked Q2 2025!

Mertz Taggart follows the publicly traded home-based care companies and reports on their earnings calls each quarter.

The recap of Home-Based Care M&A activity is now available in our M&A Report! Read all about the transactions that marked Q2 2025!

The recap of Behavioral Health M&A activity is now available in our M&A Report! Read all about the transactions that marked Q1 2025!

Mertz Taggart follows the publicly traded home-based care companies and reports on their earnings calls each quarter.

The recap of Home-Based Care M&A activity is now available in our M&A Report! Read all about the transactions that marked Q1 2025!

Mertz Taggart follows the publicly traded home-based care companies and reports on their earnings calls each quarter.

The recap of Behavioral Health M&A activity is now available in our M&A Report! Read all about the transactions that marked Q4 2024!

The recap of Home-Based Care M&A activity is now available in our M&A Report! Read all about the transactions that marked Q4 2024!

Mertz Taggart follows the publicly traded home-based care companies and reports on their earnings calls each quarter.

Deal volume across the behavioral healthcare sector continued to drop in the third quarter of 2024 to levels not seen since the onset of...

The recap of Home-Based Care M&A activity is now available in our M&A Report! Read all about the transactions that marked Q3 2024!